No conviction changes recorded
Fair Value Distribution — percentile bands
93.6% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
1.9%/yr
±3.5% · revenue growth to justify current price
FCF-Based Reverse DCF
6.1%/yr
±2.7% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
KEY VALUE DRIVERS
Spearman correlation — what moves this valuation most
Eagle will generate this view by the next trading session (~7h).
Eagle will generate this view by the next trading session (~7h).
DOC FY2025 10-K: Merged with PRT (March 2024), now 689-property diversified healthcare REIT. .36B combined OM+Lab NOI, 34 senior housing communities planned for Janus Living IPO separation (H1 2026). ...